LGND
#1193
Ligand Pharmaceuticals Incorporated - Common Stock
313.8 7 USD
-0.01%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.75%
Monthly Change
+23.09%
6 month change
+51.03%
Year Change
+67.74%
Previous Close
316.2 4
Open
315.1 8
Low
311.3 3
High
315.3 3
Volume
62
Financials
- Market Capitalization 6.29 B
- Employee 47
- Founded N/A
- CEO N/A
- Website www.ligand.com
- Headquarter Delaware, United States
- FIGI BBG000BKF014
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
30.84
Price to sales ratio
14.31
Dividends per share
2.5
Dividend yield %
1.32
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1177 |  COGT Cogent Biosciences, Inc. - Common Stock | 37.34 USD | -3.94% | -4.65% | +14.68% | +138.29% | 6.38 B USD | ||
| 1191 |  LQDA Liquidia Corporation - Common Stock | 70.59 USD | -9.42% | -12.04% | +0.28% | +212.35% | 6.28 B USD | ||
| 1246 |  BLTE Belite Bio Inc - American Depositary Shares | 148.31 USD | -0.68% | -2.56% | +7.76% | +134.82% | 5.83 B USD | ||
| 1267 |  ERAS Erasca, Inc. - Common Stock | 17.91 USD | -3.35% | -2.82% | +25.60% | +1152.45% | 5.57 B USD |
Frequently asked questions about Ligand Pharmaceuticals Incorporated - Common Stock
What is the Ligand Pharmaceuticals Incorporated - Common Stock stock price today?
The current price of Ligand Pharmaceuticals Incorporated - Common Stock (LGND) is 313.87. Over the past 24 hours, the stock has changed by -0.75%. Follow the LGND chart for real-time price dynamics.
What is the stock ticker of Ligand Pharmaceuticals Incorporated - Common Stock?
Ligand Pharmaceuticals Incorporated - Common Stock trades under the ticker LGND. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Ligand Pharmaceuticals Incorporated - Common Stock stock going up?
LGND has changed by -1.65% over the last week, +23.09% over the last month, and +67.74% over the last year. Review the chart to see whether the current move is part of a broader trend.
Does Ligand Pharmaceuticals Incorporated - Common Stock release financial reports?
Yes. You can track Ligand Pharmaceuticals Incorporated - Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What was Ligand Pharmaceuticals Incorporated - Common Stock net income for the last quarter?
Ligand Pharmaceuticals Incorporated - Common Stock reported net income of -13.35 M for the last quarter. The previous quarter showed 44.78 M, which means net income changed by -129.80%.
How many employees does Ligand Pharmaceuticals Incorporated - Common Stock have?
As of the latest available data, Ligand Pharmaceuticals Incorporated - Common Stock has 47 employees. Workforce size can provide additional context about the company's scale and operations.
What is Ligand Pharmaceuticals Incorporated - Common Stock EBITDA?
Ligand Pharmaceuticals Incorporated - Common Stock EBITDA is -6.62 M, and its EBITDA margin is -12.8%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Ligand Pharmaceuticals Incorporated - Common Stock stock?
You can buy Ligand Pharmaceuticals Incorporated - Common Stock (LGND) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Ligand Pharmaceuticals Incorporated - Common Stock stock?
Investing in Ligand Pharmaceuticals Incorporated - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the LGND chart and related analysis on metatrader.com as part of your research.